Gulf Breeze

Resilience Network


You are here

Analysis

How Feds Decide On Remdesivir Shipments To States Remains Mysterious

By the second week in July, COVID-19 cases in North Carolina were climbing fast.

With nearly 19,000 diagnoses over the previous two weeks, only five states recorded more new coronavirus cases than North Carolina did.

"Today is our highest day of hospitalizations and our second-highest day of cases," Gov. Roy Cooper, a Democrat, announced on July 9, standing behind a podium in the state's Emergency Operations Center. "Please continue to treat the virus like the deadly threat that it is."

One of the few treatment options for patients seriously ill with COVID-19 is the antiviral drug remdesivir. Authorized by the Food and Drug Administration in May for emergency use in the pandemic, remdesivir is in short supply. The federal government has taken on the responsibility for deciding where vials of the medicine should go.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Coronavirus Doctors Battle Another Scourge: Misinformation

Doctors on the front lines of the global pandemic say they are fighting not just the coronavirus, but also increasingly combating a never-ending scourge of misinformation about the disease that is hurting patients.

Problem, Solution, SitRep, or ?: 

Trail of bubbles leads scientists to new coronavirus clue

doctor checking comatose COVID-19 patients for signs of a stroke instead stumbled onto a new clue about how the virus may harm the lungs -- thanks to a test that used tiny air bubbles and a robot.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Problems with inaccurate COVID-19 tests

WASHINGTON (AP) — A widely used coronavirus test is under scrutiny this week after federal health officials warned that it could deliver inaccurate results if laboratory technicians don’t follow the the latest updates from the manufacturer.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

What if ‘Herd Immunity’ Is Closer Than Scientists Thought?

To achieve so-called herd immunity — the point at which the virus can no longer spread widely because there are not enough vulnerable humans — scientists have suggested that perhaps 70 percent of a given population must be immune, through vaccination or because they survived the infection.

Now some researchers are wrestling with a hopeful possibility. In interviews with The New York Times, more than a dozen scientists said that the threshold is likely to be much lower: just 50 percent, perhaps even less. If that’s true, then it may be possible to turn back the coronavirus more quickly than once thought.

The new estimates result from complicated statistical modeling of the pandemic, and the models have all taken divergent approaches, yielding inconsistent estimates. It is not certain that any community in the world has enough residents now immune to the virus to resist a second wave.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Analysis
howdy folks